Press release
COVID-19 UPDATE: INFECTIOUS DISEASE DRUG MARKET IS GROWING GLOBALLY WITH: F. HOFFMANN-LA ROCHE LTD, GILEAD SCIENCES, INC., GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON SERVICES, INC
Global Infectious Disease Drug Market
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-disease-drug-market
Global Infectious Disease Drug Market By Source Type (Bacterial Diseases, Virusal Diseases, Fungal Disease and Parasitic Disease), By Disease Type (Jaundice, Leprosy, Listeria, Lyme disease, Malaria, Measles, Molluscum contagiosum, Molluscum contagiosum, Norovirus, Pyelonephritis, Rabies, Severe acute respiratory syndrome, Sepsis, Tetanus, West Nile, Zika, Ebola disease and Others) By Treatment Type (Medication, Dietary supplements and surgery), By Mode of Action Type (Antibacterial drugs, Antiviral drugs, Antifungal drugs, Antiparasitic drugs ), By Drug Type (Tafenoquine, Omadacycline, Tecovirimat, Eravacycline, Delafloxacin, Plazomicin, Benznidazole, Secnidazole, Daclatasvir, Dalbavancin and Others), By Route of Administration (Oral, Topical and intravenous), By End- users (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026
Key Market Competitors
Few of the major competitors currently working in the Infectious Disease market are F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Vertex Pharmaceuticals Incorporated, ViiV Healthcare group of companies, Sanofi S.A, Eli Lilly and Company, Novartis AG, Mitsubishi Tanabe Pharma Corporation and few among others.
Competitive Landscape
Global Infectious Disease Drug Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Infectious Disease market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Insights in the report:
• Complete and distinct analysis of the market drivers and restraints
• Key Market players involved in this industry
• Detailed analysis of the Market Segmentation
• Competitive analysis of the key players involved
Market Drivers
Increases of cases of prevalence rate of infectious diseases worldwide
Advances in nutrition, antibiotics and immunization
Accelerate demanding of novel therapies and newer development in diagnostic devices
Rising awareness about treatment and technological advancement is driving the growth of market
Prevalence of indoor as well as outdoor infections
Government initiatives programs in sanitization and regulations for food safety
Market Restraints
Effective treatment is either unavailable or unaffordable.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Lack of awareness among the patient and physician about asthma disease treatment.
Grab Your Report at an Impressive 30% Discount! Please click Here@ https://www.databridgemarketresearch.com/request-a-discount/global-infectious-disease-drug-market
Key Developments in the Market:
On 01 May 2019, Sanofi S.A received FDA approval for Dengvaxia (Dengue Tetravalent Vaccine, Live) for the prophylaxes of dengue disease caused by dengue virus serotypes (1, 2, 3 and 4) in patient upto 9 years old. Dengvaxia also received European Commission approval for treatment of Dengue fever in European endemic areas.
On 8 April 2019, ViiV Healthcare group of companies received FDA approval for Dovato (dolutegravir and lamivudine), a fixed dose combination for the treatment of HIV-infected adults patients who have never treated by any antiretroviral drugs.
0n 13 Feb 2019, Novartis AG received the FDA approval for Egaten (triclabendazole) for the treatment of liver flukes specifically caused by fascioliasis and paragonimiasis. WHO recognized Egaten in an essential medicines lists.
Market Segmentation:-
To comprehend Global Infectious Disease Drug market dynamics in the world mainly, the worldwide Infectious Disease Drug market is analyzed across major global regions.
North America: United States, Canada, and Mexico.
South & Central America: Argentina, Chile, and Brazil.
Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
Europe: UK, France, Italy, Germany, Spain, and Russia.
Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Some of the Major Highlights of TOC covers:
Chapter 1: Methodology & Scope
Definition and forecast parameters
Methodology and forecast parameters
Data Sources
Chapter 2: Executive Summary
Business trends
Regional trends
Product trends
End-use trends
Chapter 3: Industry Insights
Industry segmentation
Industry landscape
Vendor matrix
Technological and innovation landscape
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-infectious-disease-drug-market
Infectious Disease Drug Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Infectious Disease Drug report provides the complete structure and fundamental overview of the industry market.
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 UPDATE: INFECTIOUS DISEASE DRUG MARKET IS GROWING GLOBALLY WITH: F. HOFFMANN-LA ROCHE LTD, GILEAD SCIENCES, INC., GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON SERVICES, INC here
News-ID: 2080565 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
